Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

SELL
N/A
-2,716 Reduced 20.34%
10,640 $90,000
Q2 2023

Aug 11, 2023

SELL
$7.79 - $10.69 $49,856 - $68,416
-6,400 Reduced 32.4%
13,356 $114,000
Q1 2023

Apr 28, 2023

SELL
$7.32 - $10.85 $11,455 - $16,980
-1,565 Reduced 7.34%
19,756 $196,000
Q3 2022

Nov 01, 2022

BUY
$10.73 - $20.07 $228,774 - $427,912
21,321 New
21,321 $229,000

Others Institutions Holding CMPS

About COMPASS Pathways plc


  • Ticker CMPS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 42,522,400
  • Market Cap $363M
  • Description
  • COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...
More about CMPS
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.